Manufacturing

Cambrex Corporation announced that it is expanding its High Point, NC facility with the addition of a new $3.2 million, 11,000 sq. ft. analytical laboratory. The investment comes in…
Read More...

Medivir AB and Ascletis announce that Ascletis has licensed the exclusive rights to develop, manufacture and commercialize Medivir's nucleotide polymerase inhibitor for hepatitis C,…
Read More...

Valeant Pharmaceuticals International announced that the U.S. Food and Drug Administration (FDA) confirmed it intends to issue a Voluntary Action Indicated (VAI) inspection…
Read More...

Avara Pharmaceutical Services has signed an agreement with Pfizer Inc. to acquire the Liscate, Italy sterile manufacturing facility. "This acquisition is an important component of our…
Read More...

QS Pharma, the Contract Development and Manufacturing Organisation (CDMO), which was acquired by Quotient Clinical in February 2017, today announced it has received approval from the…
Read More...

Boehringer Ingelheim announced a $217 million investment to upgrade and expand their Fremont manufacturing facility. This investment will bring nearly 300 new high-wage and…
Read More...

Glenmark Pharmaceuticals, a global pharmaceutical company, announced that it has entered into a development, license, manufacture and commercial supply agreement with Cyndea Pharma…
Read More...

Eurofins Scientific, a global leader in bio-pharmaceutical products testing, and one of the world leaders in genomic services, announces that it has signed an exclusive agreement with…
Read More...

Sun Pharma and Samsung BioLogics announced a strategic long-term manufacturing agreement for Tildrakizumab. The agreement was entered into by Sun Pharma's wholly-owned subsidiary and…
Read More...

Trovagene, a precision medicine biotechnology company, announced it has executed a supplier agreement with NerPharMa, S.r.l., a pharmaceutical manufacturing company and a subsidiary of…
Read More...

QS Pharma, the Contract Development and Manufacturing Organisation (CDMO), which was acquired by Quotient Clinical in February 2017, announced it has received approval from the European…
Read More...

Baxter International announced an agreement with Dorizoe Lifesciences Limited (Dorizoe), a full-service global contract research and development (R&D) organization, that will…
Read More...

SGS announced that it has significantly increased its capabilities to undertake extractables and leachables (E&L) testing at its Shanghai, China, laboratory. Its investment…
Read More...

Tekni-Plex, Inc. is announcing a $15 million investment in a new state-of-the-art manufacturing facility in Suzhou, China, near Shanghai. It represents the single largest recent…
Read More...

On 3 May 2017, Lonza successfully completed the acquisition of PharmaCell B.V., one of the most-respected cell and gene contract manufacturers in Europe with employees in Maastricht and…
Read More...

Lysogene and Brammer Bio has entered into manufacturing agreement. Brammer Bio will produce an AAVrh10-based gene therapy, LYS-GM101 for clinical testing of the therapeutic candidate in…
Read More...

LSNE Contract Manufacturing announced that it has signed a manufacturing supply agreement with Selecta Biosciences to support the development of biologic therapies for rare and serious…
Read More...

Merck announced its collaboration with Stelis Biopharma to open its first joint Process Scale-Up Lab at the Stelis Biopharma R&D Facility in the Jigani industrial estate, Bangalore.…
Read More...

Catalent Pharma Solutions announced that it will commercially manufacture Lexicon Pharmaceuticals, XERMELO following the FDA  approval at its Kansas City facility. XERMELO…
Read More...

Sorrento Therapeutics  announced that Levena has completed construction and put into operation a 25,000 square foot GMP (Good Manufacturing Practice) manufacturing facility in Suzhou,…
Read More...